Skip to main content
Joseph Khoury, MD, Pathology, Houston, TX

JosephDKhouryMD

Pathology Houston, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Khoury is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Khoury's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161
    Fax+1 702-732-8831

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2002 - 2003
  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2001 - 2002
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2001
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2026
  • NE State Medical License
    NE State Medical License 2022 - 2026
  • TX State Medical License
    TX State Medical License 2011 - 2026
  • NV State Medical License
    NV State Medical License 2006 - 2013
  • TN State Medical License
    TN State Medical License 2004 - 2013
  • OH State Medical License
    OH State Medical License 2000 - 2001
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Journal Articles

  • CD123 Expression Patterns and Selective Targeting with a CD123-Specific Antibody-Drug Conjugate (IMGN632) in Acute Lymphoblastic Leukemia  
    L Jeffrey Medeiros, Hagop M Kantarjian, Jeffrey L Jorgensen, Marina Konopleva, Elias J Jabbour, Joseph D Khoury, Sa A Wang, Sergej N Konoplev, Haematologica
  • Focal Rosai–Dorfman Disease Coexisting with Lymphoma in the Same Anatomic Site: A Localized Histiocytic Proliferation Associated with MAPK/ERK Pathway Activation  
    Shaoying Li, L Jeffrey Medeiros, Joseph D Khoury, Nature
  • Clinicopathologic and Molecular Features in Hairy Cell Leukemia-Variant: Single Institutional Experience  
    Tariq Muzzafar, L Jeffrey Medeiros, Xinyan Lu, Joseph D Khoury, Nature

Abstracts/Posters

  • Efficacy of Targeted Therapy in Novel Pre-Clinical in Vitro and In Vivo Models of Richter Transformation-Diffuse Large B-Cell Lymphoma (RT-DLBCL)
    Joseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)
    Joseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • p53 Mediated Bone Marrow Mesenchymal Stem Cell Expansion Supports Acute Myeloid Leukemia Development
    Joseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Novel BET Protein Degrader-Based Combinations Exert Lethality Against Human AML Resistant to BET Inhibitors Due to Increased Activity of β-Catenin-TCF7L2- MYC Axis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromoso... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Remembering Immunology Educator, Researcher Tom McDonald, PhD
    Remembering Immunology Educator, Researcher Tom McDonald, PhDOctober 7th, 2024
  • CAP Releases Updates to Cancer Protocols, Essential for Cancer Reporting and Patient Care
    CAP Releases Updates to Cancer Protocols, Essential for Cancer Reporting and Patient CareJuly 1st, 2021
  • Angle PLC Announces Leading US Hematopathologist Appointed as Advisor
    Angle PLC Announces Leading US Hematopathologist Appointed as AdvisorNovember 28th, 2018

Grant Support

  • Molecular PathologyNational Cancer Institute2007–2011